Cerus (CERS) Cash from Financing Activities (2010 - 2026)
Cerus' (CERS) quarterly Cash from Financing Activities came in at $1.2 million in Q1 2026, up 11.3% year-on-year from $1.1 million in Q1 2025, and up 215.62% quarter-over-quarter from -$1.0 million in Q4 2025.
Cerus (CERS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Cerus has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $1.2 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $1.2 million, up 11.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $352000.0 (down 25.74% YoY), and the FY2025 annual result was $231000.0, down 95.35% from the prior year.
- Cash from Financing Activities came in at $1.2 million for Q1 2026 at Cerus, up from -$1.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.6 million in Q3 2023 to a low of -$1.4 million in Q2 2024.
- The 5-year median for Cash from Financing Activities is $746000.0 (2024), against an average of $1.3 million.
- Across the five-year window, Cash from Financing Activities jumped 601.29% in 2023 and tumbled 710.98% in 2024, its largest moves.
- Cerus' Cash from Financing Activities stood at $457000.0 in 2022, then soared by 158.86% to $1.2 million in 2023, then tumbled by 36.94% to $746000.0 in 2024, then plunged by 238.2% to -$1.0 million in 2025, then surged by 215.62% to $1.2 million in 2026.
- The last three Cash from Financing Activities figures came in at $1.2 million (Q1 2026), -$1.0 million (Q4 2025), and $320000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 320,000.00 |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | -129,000.00 |
| Jun 30, 2025 | -129,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 746,000.00 |
| Dec 31, 2024 | 746,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |